期刊文献+

醒脑开窍针刺法改善震颤麻痹的临床观察 被引量:10

Clinical Observation of Using "Xingnaokaiqiao" Acupuncture Method to Improve Tremor Paralysis
下载PDF
导出
摘要 目的:观察醒脑开窍针刺法治疗帕金森病的临床疗效。方法:选择本院门诊及住院中符合纳入标准的80例帕金森病患者,随机分为治疗组、对照组,治疗组采用醒脑开窍针刺法加美多巴治疗,对照组单纯采用美多巴治疗,共2个疗程40天,治疗前后进行Webster评级。结果:80例纳入病例中肝肾不足、气血两虚、血瘀动风分别占40%、26.25%、20%;两组总有效率比较,p<0.05,有统计学意义。结论:中医颤证以肝肾不足居多;醒脑开窍针刺法联合美多巴能够有效地加强帕帕金森病的疗效。 Objective:To observe clinical effects of "xingnaokaiqiao" acupuncture method on Parkinson's disease. Methods: 80 patients were divided into the therapeutic group and the control group at random, both groups were given madopa, and the therapeutic group were added "xingnaokaiqiao" acupuncture, scoring the groups before a^td after therapy on Webster scale. Results:After treatment of 2 therapeutic courses, insufficiency of liver and kidney, qi-blood deficiency, blood stasis dynamic wind's degrees represented ratios of 40% , 26.25% , 20%. The curative effect of the therapeutic group was better than that of the control group. (p 〈 0. 05). Conclusion: Insufficiency "of liver and kidney was the most symptom of the disease. "Xingnaokaiqiao" acupuncture method with madopa can effectively strengthen the curative effect of Parkinson's disease.
机构地区 垫江县中医院
出处 《川北医学院学报》 CAS 2011年第2期136-138,共3页 Journal of North Sichuan Medical College
基金 重庆市科技局项目(编号:2005-D-28)
关键词 帕金森病 醒脑开窍针刺法 美多巴 疗效 Parkinsons disease "Xingnaokaiqiao" acupuncture method Madopa Clinical effects
  • 相关文献

参考文献3

二级参考文献16

  • 1Parkinson Study Group.Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.N Engl J Med,1993,328:176-183.
  • 2Riederer P,Lachenmayer L.Selegiline's neuroprotective capacity revisited.J Neural Transm,2003,110:1273-1278.
  • 3Shults CW,Oakes D,Kieburtz K,et al.Effects of coenzyme Q10 in early Parkinson disease:evidence of slowing of the functional decline.Arch Neurol,2002,59:1541-1550.
  • 4Albin RL,Frey KA.Initial agonist treatment of Parkinson disease.Neurology,2003,60:390-394.
  • 5Olanow W,Schapira AH,Rascol O.Continuous dopamine-receptor stimulation in early Parkinson's disease.Trends Neurosci,2000,23(10 Suppl):S117-S126.
  • 6Olanow CW,Watts RL,Koller WC.An algorithm (decision tree)for the management of Parkinson's disease (2001):treatment guidelines.Neurology,2001,56(11 Suppl 5):S1-S88.
  • 7Junghanns S,Glockler T,Reichmann H.Switching and combining of dopamine agonists.Neurol,2004,251 Suppl 6:VI/19-23.
  • 8Olanow CW,Stocchi F.COMT inhibitors in Parkinson's disease can they prevent and/or reverse levodopa-induced motor complications?Neurology,2004,62 Suppl 1:S72-S81.
  • 9Waters C.Other pharmacological treatments for motor complications and dyskinesias.Mov Disord,2005,20 Suppl Ⅱ:S38-S44.
  • 10Shiraishi M,Kamo T,Hotta M,et al.Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease.J Neural Transm,2004,111:725-732.

共引文献587

同被引文献183

引证文献10

二级引证文献169

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部